Biotech & Health

Auto Added by WPeMatico

Reed Jobs would rather talk about curing cancer than his last name

When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was still reeling from its post-pandemic crash. Now, the venture outfit has a team of 17; a cluster of blockbuster drugs are all losing patent protection in roughly the same window, creating all kinds of new opportunities; and AI has gone from a curiosity to, in Jobs’s words, a huge part of what Yosemite does. “I didn’t expect Yosemite to be moving this fast,” he said.

Reed Jobs would rather talk about curing cancer than his last name Read More »

I went to the so-called ‘steroid Olympics,’ to understand why Silicon Valley is obsessed with peptides

The Enhanced Games — a singular sporting competition where a majority of the athletes were on performance enhancing drugs — may herald a new business model that the tech industry is ready to embrace.

I went to the so-called ‘steroid Olympics,’ to understand why Silicon Valley is obsessed with peptides Read More »

Shopping Cart